Grants
The Fundación Conchita Rábago has awarded two grants since it was founded in 1969.
One to train predoctoral researchers at the Fundación Jiménez Díaz .
The other provides assistance to doctors from the Jiménez Díaz Foundation, enabling them to broaden their education at other national and international centres so that the home institution can benefit from what they learn.
The Board of Trustees of the Conchita Rábago Foundation
CALL
Jiménez Díaz Predoctoral Research Fellowships in accordance with the following rules:
1.- The Scholarships will last one year, from January to December 2026.
2.- They will be provided with an allocation to be determined.
3.- In order to enjoy these Scholarships, full dedication to a funded research project, assigned to a principal investigator of the IIS-FJD based at the Jiménez Díaz Foundation in Madrid, will be essential.
4.- The deadline for submitting applications will end on November 17.
5.- The application must be sent by post to the Conchita Rábago de Jiménez Díaz Foundation (Calle Príncipe de Vergara 9, 5º Izda. 28001 Madrid). A complete scanned copy with signatures must also be sent by email to isabelferreiro@fundacionconchitarabago.net. Applications must include the following documentation:
1. Cover Letter containing the following information:
- Director of the scholarship (Name and surname, Position, Department, IIS-FJD Area).
- Scholarship candidate (Name and surname).
- Project (funded project, agency and effective date) and Title of the Grant project.
- The letter must be signed by the Scholarship Director and the Candidate.
2. Corresponding application form duly completed.
3. Updated CV.
4. Certificate of studies (only for new requests)
Candidates must have graduated within the last five years as of the year for which the call is requested.
6.- This Board of Trustees may request a report on the progress of the research at any time while enjoying the Scholarship. If this is not satisfactory, the Scholarship may be rescinded.
Fellows 2026
Third year
DE LA RIVA BUENO, MACARENA
Bachelor: Health Biology
University: University of Alcalá – 2023
Master: Master of Research in Translational Medicine 2023/24
IIS-FJD Area: Infectious, Inflammatory and Chronic Diseases
Group: Rheumatology and Bone Metabolism
Director: Dr. Aranzazu Mediero Muñoz
Group type: Emerging
Project: Study of the comorbidity of non-alcoholic fatty liver in patients with rheumatoid arthritis and involvement of the purinergic system as therapy.
Funded project to which it is attached:
MODULATION OF THE PURINERGIC SYSTEM WITH AGENTS THAT INCREASE EXTRACELLULAR LEVELS
OF ADENOSINE AS POTENTIAL THERAPEUTIC TARGETS FOR SARCOPENIA.
Agency: ISCIII
Reference: PI22/00347
Funded period: 2023-2025
FRUTOS DÍAZ ALEJO, JESÚS
Bachelor: Health Biology
University: University of Alcalá - 2019
Master: Therapeutic targets in cell signaling: research and development - 2019/20
IIS-FJD Area: Cancer
Group: Pathological Anatomy. Lymphoma
Director: Dr. Socorro María Rodríguez Pinilla
Group type: Emerging
Project: Molecular characterization of Angioimmunoblastic T Lymphoma.
Funded project to which it is attached:
COMPREHENSIVE MOLECULAR STUDY OF TANGIOIMMUNOBLASTIC LYMPHOMA.
Agency: Carlos III Health Institute (ISCIII)
Reference: PI21/01724
Funded period: 2022-2026
LÓPEZ LÓPEZ, LUCÍA
Double Bachelor: Pharmacy and Biotechnology
University: CEU San Pablo Madrid University – 2022
Master: Master in Bioinformatics and Data Science in Personalized Precision Medicine and Health
2023/24
IIS-FJD Area: Genetics and Genomics
Group: Genetics and Genomics of Rare Diseases
Director: Dr. Berta Almoguera Castillo
Group type: Emerging
Project: Identification of mechanisms involved in the etiology and clinical presentation of neurodevelopmental disorders with genomic, epigenomic and transcriptomic approaches.
Funded project to which it is attached:
IDENTIFICATION OF MECHANISMS INVOLVED IN THE ETIOLOGY AND CLINICAL PRESENTATION OF NEURODEVELOPMENTAL DISORDERS WITH GENOMIC, EPIGENOMIC AND TRANSCRYPTOMIC APPROACHES.
Agency: ISCIII
Reference: PI23/00477
Funded period: 2024-2026
ROCHANO ORTIZ, ANTONIO
Bachelor: Biology
University: Complutense University of Madrid - 2022
Master: Molecular Biomedicine- 2022/23
IIS-FJD Area: Kidney, Metabolic and Cardiovascular Diseases
Group: Vascular and Renal Pathology. Cardiovascular Metabolism
Director: Dr. Jorge Oller Pedrosa
Group type: Emerging
Project: New molecular targets in vascular diseases and Marfan Syndrome
Funded project to which it is attached:
NEW METABOLIC THERAPEUTIC TARGETS IN AORTOPATHIES
Agency: Ministry of Science and Innovation
Reference: PID2022-137730OA-100
Funded period: 2023-2026
ROMERO COTE, MARÍA
Bachelor: Biology
University: University of Córdoba – 2019
Master: Master's Degree in Translational Biomedical Research 2019/20
IIS-FJD Area: Kidney, Metabolic and Cardiovascular Diseases
Group: Nephrology
Director: Dr. Emilio González Parra
Group type: Consolidated
Project: Impact of aromatic uremic toxins and bisphenols on oxidation and inflammation in patients with chronic kidney disease (CKD). Role in the progression of vascular and nutritional damage
Funded project to which it is attached:
IMPACT OF AROMATIC UREMIC TOXINS AND BISPHENOLS ON OXIDATION AND INFLAMMATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD). ROLE IN THE PROGRESSION OF VASCULAR AND NUTRITIONAL DAMAGE
Agency: ISCIII- Ministry of Science and Innovation
Reference: PI21/01430
Funded period: 2022-2025
Second year
GONZÁLEZ GONZÁLEZ, JESÚS
Bachelor: Biology
University: Universidad Autónoma de Madrid - 2023
Master's Degree (IN PROGRESS): Health Biology - 2024/25
IIS-FJD Area: Genetics and Genomics
Group: Genetics and Genomics of Rare and Complex Diseases
Director: Dr. Ana Osorio Cabrero
Type of group/ PI: Consolidated
Project: Genetic architecture of familial breast cancer: completing the puzzle.
Funded project to which it is attached:
GENETIC ARCHITECTURE OF FAMILIAL BREAST CANCER: COMPLETING THE PUZZLE.
Agency: Instituto de Salud Carlos III
Reference: PI23/01235
Funded period: 2024 - 2026
LÓPEZ ALCOJOR, AROA
Bachelor: Biology
University: Universidad Autónoma de Madrid - 2023
Master: Biotechnology - 2024
Area IIS-FJD: Genetics and Genomics
Group: Genetics and Genomics of Rare and Complex Diseases
Director: Dr. Carmen Ayuso García
Co-Director: Dr. Marta Cortón Pérez
Type of group/ PI: Consolidated
Project: Genomic discovery and characterization of retinal dystrophies, applying short and long sequence genomic sequencing tools and bioinformatics and AI algorithms.
Funded project to which it is attached:
IMPACT-GENOMICS 2: ADVANCING TOWARDS PRECISION MEDICINE IN RARE DISEASES AND LOW-FREQUENCY TUMORS
Agency: FIS , ISCIII
Reference: PMPER24/00002
Funded period: 2025 - 2027
MIÑO IZQUIERDO, LUCÍA
Bachelor: Pharmacy
University: Universidad Complutense de Madrid - 2023
Master's Degree: Biotechnology - September 2024
IIS-FJD Area: Renal, Metabolic and Cardiovascular Diseases
Group: Experimental Nephrology
Director: Dr. Ana Belén Sanz Bartolomé
Type of group/ PI: Consolidated
Project: Identification and characterization of new RIPK3-dependent mediators of renal damage.
Funded project to which it is attached:
NEW DIAGNOSTIC AND THERAPEUTIC APPROACHES TO PREVENT CELL DEATH AND INFLAMMATION ACTIVATED BY RIPK3.
AND INFLAMMATION ACTIVATED BY RIPK1 AND RIPK3 IN ACUTE RENAL FAILURE.
Agency: Instituto de Salud Carlos III
Reference: PI22/00469
Funded period: 2023 - 2027
Translated with DeepL.com (free version)
SELVA GIMÉNEZ, MARTA
Bachelor: Biochemistry and Biomedical Sciences
University: University of Valencia - 2019
Master (IN PROGRESS): Precision Human Genomics - 2024/25
IIS-FJD Area: Cancer
Group: Medical Oncology
Director: Dr. Ángela Lamarca Lete
Type of group/ PI: Emerging
Project: Role and regulation of protein phosphatase activity 2A
in cholangiocarcinoma: impact on prognosis and prediction of pharmacological response.
Funded project to which it is attached:
ROLE AND REGULATION OF PROTEIN PHOSPHATASE 2A ACTIVITY IN CHOLANGIOCARCINOMA:
IMPACT ON PROGNOSIS AND PREDICTION OF PHARMACOLOGICAL RESPONSE.
Agency: Instituto de Investigación Carlos III- AES FIS
Reference: PI23/01070
Funded period: 2024 - 2026
SERRANO SANTIAGO, ANTONIO
Bachelor: Biomedicine
University: Universidad Francisco de Vitoria Madrid - 2024
Master (IN PROGRESS): Research in Immunology- 2024/25
IIS-FJD Area: Infectious, Inflammatory and Chronic Diseases
Group: Allergy and Immunology
Director: Dr. José Antonio Cañas Mañas
Co-Director: Dr. María Victoria del Pozo Abejón
Type of group/ PI: Consolidated / Emerging
Project: New diagnostic and therapeutic tools in pediatric asthma: Action of extracellular vesicles and microRNAs on the eosinophil.
Funded projects to which it is attached:
EXOSOMES AND MICRORNAS:
1. NOVEL THERAPEUTIC AND DIAGNOSTIC TOOLS IN THE INTERACTION OF ASTHMA AND FOOD ALLERGY.
Agency: Instituto de Salud Carlos III
Reference: CP23/00017
Funded period: 2024 - 2029
2. TRIUMFAS: PERSONALIZED TREATMENT IN SEVERE EOSINOPHILIC ASTHMA WITH BIOLOGICS:
CAN IT MODIFY THE COURSE OF THE DISEASE?
Agency: Instituto de Salud Carlos III
Reference: PI24/00024
Funded period: 2025 - 2027
First año
ARGUIÑANO HOLGUÍN, CLAUDIA
Bachelor's Degree: Biology
University: University of Salamanca – 2021
Master's Degree Completed: Biomedical Research University of the Basque Country – 2022
Current Master's Degree: Bioinformatics and Biostatistics IIS-FJD
Area: Cancer
Group: Pathology
Director: Dr. Federico Rojo Todo
Co-Director: Dr. Juan Madoz Gúrpide
Group Type/PI: Consolidated
Project:
Role of the Hippo signaling pathway in resistance to trastuzumab-deruxtecan therapy in HER2-low breast cancer
Funded project to which this research belongs:
PRECLINICAL AND CLINICAL CHARACTERIZATION OF THE ROLE OF LCOR AND THE HIPPO SIGNALING PATHWAY IN RESISTANCE TO ANTI-HER2 THERAPIES IN HER2-POSITIVE BREAST CANCER
Agency: Carlos III Health Institute III Reference: PI24/00160
Funding period: 01/01/2025 - 31/12/2027
DE MARÍA CAMACHO, IRENE
Bachelor's Degree: Biology
University: Complutense University of Madrid – 2023
Master's Degree: Health Biology UCM – 2023/25 IIS-FJD
Area: Infectious, Inflammatory, and Chronic Diseases
Group: Allergy Director: Dr. Vanesa Esteban Vázquez
Group Type/PI: Consolidated
Project:
Characterization of the monocyte/macrophage/endothelium in anaphylaxis. Diagnostic or therapeutic implications?
Funded project to which this research belongs:
Differential diagnosis of allergic reactions and anaphylaxis. Therapeutic implications of the microenvironments related to extracellular vesicles and the endothelial glycocalyx.
Agency: Carlos III Health Institute
Reference: PI24_00360
Funding period: 2025-2027
DE HERAS PINO, PALOMA
Bachelor's Degree: Health Biology
University: University of Alcalá de Henares (UAH) – 2023
Master's Degree: Therapeutic Targets in Cell Signaling (R&D). UAH – 2024 IIS-FJD
Area: Cancer Group: Medical Oncology
Director: Dr. Arancha Cebrián Aranda
Co-Director: Dr. Jesús García-Foncillas
Group Type/PI: Consolidated
Project:
Identification of epigenetic targets to overcome treatment resistance in metastatic colorectal cancer
Funded Project to which it belongs:
EPIGENETIC MODULATION OF PHENOTYPIC PLASTICITY AS A RESISTANCE MECHANISM IN METASTATIC COLORECTAL CANCER
Agency: Carlos III Research Institute
Reference: PI25/01771
Funding Period: 01/01/2026 - 31/12/2028
HERRERO DEL REAL, ISABEL
Bachelor's Degree: Biochemistry
University: Complutense University of Madrid - 2022
Master's Degree: Pharmacological Research. UAM - 2023 IIS-FJD
Area: Renal, Metabolic, and Cardiovascular Diseases
Group: Vascular, Renal, and Diabetes Pathology
Director: Dr. Carmen Gómez Guerrero
Group Type/PI: Consolidated
Project:
Peptidomimetic-Based Therapy for Metabolic Liver Disease: From Structural Optimization to Preclinical Validation
Funded projects to which it is affiliated:
• DEVELOPMENT OF INNOVATIVE DRUGS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND LIVER FIBROSIS Agency: Carlos III Health Institute (Health Technology Development Projects)
Reference: DTS25/00051 Funding period: 2025-2028
• REGULATION OF MICRORNA-mRNA AND PROTEIN-PROTEIN INTERACTIONS IN DIABETES AND ASSOCIATED METABOLIC DISEASES: PATHOLOGICAL AND THERAPEUTIC INTERACTIONS
Agency: Ministry of Science, Innovation and Universities
Reference: PID2021-127741OB-I00
Funding period: 01/09/2022–31/08/2025 (Extended until 31/08/2026)
MACÍAS GAMERO, INÉS
Bachelor's Degree: Biomedicine
University: Alfonso X el Sabio University – 2024
Master's Degree: Research, Development, Control, and Innovation of Medicines.
University of Granada – 2025 IIS-FJD
Area: Renal, Metabolic, and Cardiovascular Diseases
Group: Vascular Pathology
Director: Dr. Nerea Méndez Barbero
Group Type/PI: Emerging
Project:
Mediators of endothelium-vascular smooth muscle cell communication in pathologies of aortic vascular remodeling; atherosclerosis and aneurysms.
Funded Project to which this research belongs:
DECIPHERING CELLULAR DIALOGUE IN THE VASCULAR WALL: KEY TO THE SEARCH FOR NEW EARLY TARGETS IN PATHOLOGICAL VASCULAR REMODELING.
Agency: Carlos III Health Institute
Reference: PI24/00180
Funding period: 01/2025 – 12/2027
REEB, CAMILA
Degree: Medicine
University: National University of Comahue (Argentina) – 2021
Master's: Translational Medicine
Research. Complutense University of Madrid – 2025
Currently enrolled in a Master's program: Bioinformatics and Biostatistics.
Open University of Catalonia and University of Barcelona IIS-FJD
Area: Genetics and Epidemiology
Group: Genetics and Genomics of Rare and Complex Diseases
Director: Dr. Ana Osorio Cabrero Group Type/PI: Consolidated
Project:
HERPROS: Genetic inheritance and prostate cancer risk in the Spanish population.
Funded project to which this researcher is affiliated:
GENETIC ARCHITECTURE OF FAMILIAL BREAST CANCER: COMPLETING THE PUZZLE.
Agency: Carlos III Health Institute
Reference: PI23/01235
Funding period: January 2024–December 2026